Kang Zhang

Kang Zhang () is a Chinese-American ophthalmologist specializing in ophthalmic genetics and aging processes in the eye. He is currently a professor of the Faculty of Medicine at Macau University of Science and Technology. He was previously a professor of ophthalmology and the founding director of the Institute for Genomic Medicine at the University of California, San Diego. In 2017, the U.S. Food and Drug Administration issued a notice related to his research oversight, and he later left UC San Diego in 2019. He subsequently moved to China and continues his research, which includes work on lanosterol. stem cell research (particularly limbal stem cells), gene editing, and artificial intelligence. Provided by Wikipedia